Correlation Analysis of TAM Subfamily of Receptor Tyrosine Kinases in Ulcerative Colitis
10.3969/j.issn.1008-7125.2022.05.001
- Author:
Yan YE
1
;
Dandan GU
1
;
Wenjuan WEI
1
;
Jiarong MIAO
1
Author Information
1. Department of Gastroenterology, First Affiliated Hospital of Kunming Medical University, Yunnan Province Clinical Research Center for Digestive Diseases
- Publication Type:Journal Article
- Keywords:
Axl;
Colitis, Ulcerative;
Mertk;
TAM Subfamily of Receptor Tyrosine Kinases;
Tyro3
- From:
Chinese Journal of Gastroenterology
2023;27(5):257-262
- CountryChina
- Language:Chinese
-
Abstract:
Background: TAM receptors (Tyro3, Axl and Mertk), as subfamily of receptor tyrosine kinases, are intracellular negative feedback regulators and play a crucial role in regulating inflammation and immune response. Aims: To study the expressions and clinical value of TAM receptors in serum and intestinal mucosa of patients with ulcerative colitis (UC). Methods: Forty⁃five patients who were initially diagnosed as active UC from June, 2020 to May, 2021 at the First Affiliated Hospital of Kunming Medical University were enrolled prospectively. Fifteen healthy subjects were served as the control group. Eight cases each in moderate UC group and healthy control group were selected randomly for detection of TAM receptors in serum and intestinal mucosa by ELISA, real⁃time PCR and Western blotting. The correlations of serum Tyro3 with routine clinical indicators of UC were analyzed by Pearson correlation coefficient. Furthermore, immunohistochemistry was used to detect the expression level of TAM receptors in intestinal mucosa in all UC patients and the healthy controls. Results: Expressions of Axl and Mertk were not fully consistent in serum and intestinal mucosa in UC patients. While the serum Tyro3 level, as well as the intestinal Tyro3 mRNA and protein expressions were consistently increased in moderate UC patients than in controls (all P<0.05). Serum level of Tyro3 was positively correlated with platelet count and C⁃reactive protein, and negatively correlated with albumin in moderate UC patients (r=0.97, r=0.96, r=-0.86, all P<0.05). Positivity rate of Tyro3 in intestinal mucosa of UC patients was positively correlated with the disease severity (all P<0.05). Conclusions: Tyro3 is closely related to UC and positively correlated with the disease severity. It might be a promising novel molecular marker and therapeutic target of UC.
